These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 7019230
1. Calcitonin, a diabetogenic hormone? Passariello N, Giugliano D, Sgambato S, Torella R, D'Onofrio F. J Clin Endocrinol Metab; 1981 Aug; 53(2):318-23. PubMed ID: 7019230 [Abstract] [Full Text] [Related]
2. Glucose metabolism in patients receiving chronic calcitonin treatment. Guigliano D, Passariello N, Sgambato S, Torella R, Ceriello A, D'Onofrio F. Diabete Metab; 1982 Sep; 8(3):213-6. PubMed ID: 6754493 [Abstract] [Full Text] [Related]
3. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. Saccà L, Sherwin R, Hendler R, Felig P. J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [Abstract] [Full Text] [Related]
4. Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects. Sgambato S, Passariello N, Giugliano D, Torella R, D'Onofrio F. Acta Diabetol Lat; 1981 May; 18(3):235-41. PubMed ID: 7029989 [Abstract] [Full Text] [Related]
5. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion. Abdul-Ghani M, DeFronzo RA. J Clin Endocrinol Metab; 2007 May; 92(5):1778-84. PubMed ID: 17327375 [Abstract] [Full Text] [Related]
6. The diabetogenic action of somatostatin in healthy subjects and in maturity onset diabetics. Waldhäusl W, Bratusch-Marrain P, Dudczak R, Deutsch E. J Clin Endocrinol Metab; 1977 May; 44(5):876-83. PubMed ID: 870515 [Abstract] [Full Text] [Related]
7. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate. Al-Waili N. Eur J Med Res; 2003 Jul 31; 8(7):295-303. PubMed ID: 12911866 [Abstract] [Full Text] [Related]
8. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Rizza RA, Cryer PE, Gerich JE. J Clin Invest; 1979 Jul 31; 64(1):62-71. PubMed ID: 36413 [Abstract] [Full Text] [Related]
9. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism. Perez G, Ungaro B, Covelli A, Morrone G, Lombardi G, Scopacasa F, Rossi R. J Clin Endocrinol Metab; 1980 Nov 31; 51(5):972-7. PubMed ID: 7419694 [Abstract] [Full Text] [Related]
10. Effect of calcitonin on insulin response to arginine in man. Sgambato S, Passariello N, Giugliano D, d'Onofrio F. Diabete Metab; 1979 Sep 31; 5(3):213-6. PubMed ID: 499636 [Abstract] [Full Text] [Related]
11. A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man. Liu D, Moberg E, Kollind M, Lins PE, Adamson U. J Clin Endocrinol Metab; 1991 Nov 31; 73(5):1123-8. PubMed ID: 1682339 [Abstract] [Full Text] [Related]
12. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections. Nauck MA, Siemsglüss J, Orskov C, Holst JJ. Z Gastroenterol; 1996 Mar 31; 34(3):159-66. PubMed ID: 8650968 [Abstract] [Full Text] [Related]
13. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity. Salera M, Giacomoni P, Pironi L, Cornia G, Capelli M, Marini A, Benfenati F, Miglioli M, Barbara L. J Clin Endocrinol Metab; 1982 Aug 31; 55(2):329-36. PubMed ID: 7045154 [Abstract] [Full Text] [Related]
14. Impaired insulin response to glucose but not to arginine in heroin addicts. Passariello N, Giugliano D, Ceriello A, Chiariello A, Sgambato S, D'Onofrio F. J Endocrinol Invest; 1986 Oct 31; 9(5):353-7. PubMed ID: 3540079 [Abstract] [Full Text] [Related]
15. Discrepant effect of the prostaglandin synthesis inhibitor acetylsalicylic acid on insulin and C-peptide response to glucose in man. Ratzmann KP, Besch W, Witt S, Schulz B. Horm Metab Res; 1982 Oct 31; 14(10):508-12. PubMed ID: 6757082 [Abstract] [Full Text] [Related]
16. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects. Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK. J Clin Endocrinol Metab; 2010 Jul 31; 95(7):3309-17. PubMed ID: 20410219 [Abstract] [Full Text] [Related]
17. Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance. Ratzmann KP, Witt S, Schulz B. Diabete Metab; 1982 Sep 31; 8(3):223-8. PubMed ID: 6754494 [Abstract] [Full Text] [Related]
18. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly. Chiba T, Chihara K, Minamitani N, Goto B, Kadowaki S, Taminato T, Matsukura S, Fujita T. Horm Metab Res; 1982 Feb 31; 14(2):57-61. PubMed ID: 7040191 [Abstract] [Full Text] [Related]
19. Effects of prostaglandin E1 and prostaglandin F2alpha on insulin and glucagon plasma levels during the intravenous glucose tolerance test in man. Giugliano D, Torella R, Improta L, D'Onofrio F. Diabete Metab; 1978 Sep 31; 4(3):187-91. PubMed ID: 710679 [Abstract] [Full Text] [Related]
20. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus. Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M. Metabolism; 2005 Sep 31; 54(9):1168-73. PubMed ID: 16125528 [Abstract] [Full Text] [Related] Page: [Next] [New Search]